Synthesis and Hybridization Studies of a New CPP-PNA Conjugate as a Potential Therapeutic Agent in Atherosclerosis Treatment

Author(s): Monika Wojciechowska, Jaroslaw Ruczynski, Piotr Rekowski, Magdalena Alenowicz, Piotr Mucha, Malgorzata Pieszko, Anna Miszka, Michal Dobkowski, Hans Bluijssen

Journal Name: Protein & Peptide Letters

Volume 21 , Issue 7 , 2014

Become EABM
Become Reviewer
Call for Editor


The objective of this study was to design and synthesize a new CPP-PNA conjugate that would be able to penetrate endothelial cells, bind STAT1 mRNA and thereby block the activity of STAT1 (the Signal Transducer and Activator of Transcription 1), which is important in cases of vessel inflammation. In the course of the study, the TAMRA-PTD-4- Hal(traziole-Gly-PNA)-conjugate was successfully synthesized using a specific 1,3-dipolar Huisgen cycloaddition reaction known as a “click reaction”. The hybridization properties of the conjugate to complementary hSTAT1 mRNA and hSTAT1 ssDNA fragments was verified by capillary electrophoresis (CE). Studies have shown that the attachment of a fluorescence-labeled peptide to a PNA sequence via a 1,2,3-triazole ring did not alter the binding properties of the PNA to the complementary hSTAT1 mRNA or hSTAT1 ssDNA fragments maintaining similar binding affinity. Furthermore, the data obtained suggest that the use of such a conjugate to modulate the activity and expression of STAT1 could provide a new therapeutic strategy for atherosclerosis treatment.

Keywords: Capillary electrophoresis, cell penetrating peptides, click reaction, CPP-PNA conjugate, peptide nucleic acids.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 20 May, 2014
Page: [672 - 678]
Pages: 7
DOI: 10.2174/0929866521666140320102034
Price: $65

Article Metrics

PDF: 18